Troels Siggaard

Research programmer

Novo Nordisk Foundation Center for Protein Research

Biografi

The Brunak Group aims for understanding multi-morbidity disease progression patterns and their relation to treatment events. The group integrates heterogeneous life science data from the molecular and clinical domains and is also engaged in methodology of translational utility, such as techniques of relevance within precision medicine.
The Brunak Group has specific interest in genes and proteins, which play a role in several diseases, genes that may rationalize clinically observed patterns of multi-morbidity, or be of interest in relation to treatment strategies in the domain of chronic pathology.
The group aims for discriminating between treatment-related disease correlations and other comorbidities, stratifying patients not only from their genotype but also on phenotypic data from resources such as clinical descriptions in electronic medical records.

Dansk
© All rights reserved, Sciencenews 2020